Fred H. Hochberg

Active 1974–2023

103
Papers
29,164
Citations
90
h-index
103
i10-index

Citations

Citations per year for Fred H. Hochberg1976: 6 citations1977: 5 citations1979: 1 citations1980: 5 citations1981: 4 citations1982: 10 citations1983: 8 citations1984: 9 citations1985: 11 citations1986: 18 citations1987: 20 citations1988: 16 citations1989: 21 citations1990: 26 citations1991: 35 citations1992: 37 citations1993: 22 citations1994: 50 citations1995: 55 citations1996: 46 citations1997: 58 citations1998: 62 citations1999: 99 citations2000: 128 citations2001: 93 citations2002: 144 citations2003: 150 citations2004: 121 citations2005: 133 citations2006: 172 citations2007: 162 citations2008: 185 citations2009: 184 citations2010: 153 citations2011: 137 citations2012: 143 citations2013: 184 citations2014: 243 citations2015: 370 citations2016: 387 citations2017: 510 citations2018: 554 citations2019: 1,175 citations2020: 1,219 citations2021: 1,190 citations2022: 854 citations2023: 606 citations2024: 828 citations2025: 430 citations2026: 11 citations1978: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,534 citing papers, 28% of this breakdownChina: 1,504 citing papers, 11.9% of this breakdownGermany: 744 citing papers, 5.9% of this breakdownUnited Kingdom: 641 citing papers, 5.1% of this breakdownItaly: 553 citing papers, 4.4% of this breakdownFrance: 401 citing papers, 3.2% of this breakdownCanada: 379 citing papers, 3% of this breakdownAustralia: 349 citing papers, 2.8% of this breakdownNetherlands: 339 citing papers, 2.7% of this breakdownJapan: 332 citing papers, 2.6% of this breakdownSpain: 323 citing papers, 2.5% of this breakdownSouth Korea: 271 citing papers, 2.1% of this breakdown
0%28%Other 25.8%

Fields

  • Biochemistry, Genetics and Molecular Biology57%
  • Medicine34.4%
  • Neuroscience1.9%
  • Immunology and Microbiology1.6%
  • Engineering1.5%
  • Materials Science1.5%
  • Other2.1%

Topics

  • Extracellular vesicles in disease16.9%
  • MicroRNA in disease regulation9.5%
  • Glioma Diagnosis and Treatment6.3%
  • RNA Interference and Gene Delivery3.6%
  • Circular RNAs in diseases2.8%
  • Brain Metastases and Treatment2.2%
  • Other58.7%

Coauthors

All papers

Open in search
  1. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research

    Authors: , , , , , , , , , , , , - Journal of Extracellular Vesicles 2013 cited by 2,417

  2. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles

    Authors: , , , , , , , , , , , , , , - Journal of Extracellular Vesicles 2014 cited by 2,687

  3. Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Magdalena J. Lorenowicz, Sai Kiang Lim, Jan Lötvall, Casey A. Maguire, Antonio Marcilla, Irina Nazarenko, Takahiro Ochiya, Tushar Patel, Shona Pedersen, Gabriella Pòcsfalvi, Stefano Pluchino, Peter J. Quesenberry, Ilona Reischl, Francisco J. Rivera, Ralf Sanzenbacher, Katharina Schallmoser, Ineke Slaper‐Cortenbach, Dirk Strunk, Torsten Tonn, Pieter Vader, Bas W. M. van Balkom, Marca H. M. Wauben, Samir EL Andaloussi, Clotilde Théry, Eva Rohde, Bernd Giebel - Journal of Extracellular Vesicles 2015 cited by 1,514

  4. The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thi Trinh, Mark A. Watson, Rebecca Aft, Siddarth Rawal, Ashutosh Agarwal, Susan B. Kesmodel, Changhuei Yang, Cheng Shen, Fred H. Hochberg, David T. Wong, Abhijit A. Patel, Nickolas Papadopoulos, Chetan Bettegowda, Richard J. Côté, Sudhir Srivastava, Hakho Lee, Bob S. Carter, Leonora Balaj - Cell Reports Medicine 2023 cited by 198

  5. Coding and noncoding landscape of extracellular RNA released by human glioma stem cells

    Authors: , , , , , , , , , , , , - Nature Communications 2017 cited by 556

  6. Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma

    Authors: , , , , , , , , , - Nature Communications 2015 cited by 607

  7. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy

    Authors: , , , , , , , , , - Nature Medicine 2012 cited by 755

  8. Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles

    Authors: , , , , , , , , , , , , , , , , , - Nature Communications 2018 cited by 331

  9. miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development

    Authors: , , , , , , , , , , , , , , - PLoS ONE 2013 cited by 330

  10. BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles

    Authors: , , , , , , , , , , , , , , , , - Molecular Therapy — Nucleic Acids 2013 cited by 343

  11. The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alton Etheridge, Marc Ferrer, Jeffrey L. Franklin, Jane E. Freedman, David J. Galas, Timur R. Galeev, Roopali Gandhi, Aitor Garcia, Mark Gerstein, Vikas Ghai, Ionita Ghiran, María D. Giraldez, Andrei Goga, Tasos Gogakos, Béatrice Goilav, Stephen J. Gould, Peixuan Guo, Mihir Gupta, Fred H. Hochberg, Bo Huang, Matt Huentelman, Craig P. Hunter, Elizabeth Hutchins, Andrew R. Jackson, M. Yashar S. Kalani, Pınar Kanlikilicer, Reka Agnes Karaszti, Kendall Van Keuren-Jensen, Anastasia Khvorova, Yong Kim, Hogyoung Kim, Taek‐Kyun Kim, Robert R. Kitchen, Richard P. Kraig, Anna M. Krichevsky, Raymond Y. Kwong, Louise C. Laurent, Min Young Lee, Noëlle D. L’Étoile, Shawn Levy, Feng Li, Jenny Li, Xin Li, Gabriel Lopez‐Berestein, Rocco Lucero, Bogdan Mateescu, A. Matin, Klaas E.A. Max, Michael T. McManus, Thorsten R. Mempel, Cindy Meyer, Aleksandar Milosavljevic, Debasis Mondal, Kenneth J. Mukamal, Oscar Murillo, Thangamani Muthukumar, Deborah A. Nickerson, Christopher J. O’Donnell, Dinshaw J. Patel, Tushar Patel, James G. Patton, Anu Paul, Elaine R. Peskind, Mitch A. Phelps, Chaim Putterman, Peter J. Quesenberry, Joseph F. Quinn, Robert L. Raffai, Saritha Ranabothu, Shannon Jiang Rao and 57 more - Cell 2019 cited by 230

  12. Impact of Biofluid Viscosity on Size and Sedimentation Efficiency of the Isolated Microvesicles

    Authors: , , , , , , - Frontiers in Physiology 2012 cited by 246

  13. Extracellular vesicles: the growth as diagnostics and therapeutics; a survey

    Authors: , , - Journal of Extracellular Vesicles 2018 cited by 145

  14. Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2017 cited by 202

  15. Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation

    Authors: , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 342

  16. Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2010 cited by 516

  17. Comparative Analysis of Technologies for Quantifying Extracellular Vesicles (EVs) in Clinical Cerebrospinal Fluids (CSF)

    Authors: , , , , , , , - PLoS ONE 2016 cited by 136

  18. Analysis of extracellular RNA in cerebrospinal fluid

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Extracellular Vesicles 2017 cited by 96

  19. Extracellular Vesicles Modulate the Glioblastoma Microenvironment via a Tumor Suppression Signaling Network Directed by miR-1

    Authors: , , , , , , , , , , , , , , , - Cancer Research 2013 cited by 231

  20. A cerebrospinal fluid microRNA signature as biomarker for glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , - Oncotarget 2017 cited by 130

  21. A Phase I Open-Label, Dose-Escalation, Multi-Institutional Trial of Injection with an E1B-Attenuated Adenovirus, ONYX-015, into the Peritumoral Region of Recurrent Malignant Gliomas, in the Adjuvant Setting

    Authors: , , , , , , , , , , , , , , , , , , , , - Molecular Therapy 2004 cited by 440

  22. Updating the MISEV minimal requirements for extracellular vesicle studies: building bridges to reproducibility

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Extracellular Vesicles 2017 cited by 236

  23. Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

    Authors: , , , , , , , , , , - Nature Medicine 1999 cited by 342

  24. A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 incombination with carboplatin administered intravenously for the treatment ofrecurrent malignant glioma

    Authors: , , , , , , , , , , , - Neuro-Oncology 2003 cited by 205